Why is Fortis Healthcare Ltd falling/rising?

Recent Price Performance and Market Context

Fortis Healthcare’s shares have been under pressure over the past week, declining by 7.98%, significantly underperforming the Sensex’s 2.66% fall during the same period. Over the last month, the stock has dropped 11.68%, again lagging behind the benchmark’s 9.34% decrease. Year-to-date, the stock is down 8.48%, although this is slightly better than the Sensex’s 11.40% decline. Despite these short-term setbacks, the stock has delivered impressive returns over longer horizons, with a 33.88% gain in the past year and an extraordinary 205.04% rise over three years, far outpacing the Sensex’s 31.00% gain in that timeframe.

However, the recent four-day consecutive fall, which has resulted in an 8.23% loss, highlights growing investor caution. The stock touched an intraday low of ₹802.8, representing a 4.39% drop on the day, with heavier trading volume concentrated near these lower price levels. This suggests selling pressure is intensifying as investors react to near-term challenges.

Technical Indicators and Investor Participation

Technically, Fortis Healthcare is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This broad-based weakness signals a bearish trend and may deter short-term traders and momentum investors. Additionally, delivery volumes have declined sharply, with a 39.66% drop from the five-day average as of 13 March, indicating waning investor participation and possibly reduced conviction among shareholders.

Fundamental Strengths Supporting Fortis Healthcare

Despite the recent price weakness, Fortis Healthcare maintains several strong fundamental attributes. The company exhibits a robust ability to service its debt, with a low Debt to EBITDA ratio of 0.91 times, which suggests manageable leverage. Operating profit has grown at an impressive annual rate of 115.19%, underscoring healthy long-term growth prospects. Institutional investors hold a significant 57.17% stake, reflecting confidence from sophisticated market participants who typically conduct thorough fundamental analysis.

Moreover, the stock has consistently outperformed the broader BSE500 index over the past three years, delivering superior returns and demonstrating resilience in various market conditions. This track record of consistent performance is a positive indicator for long-term investors.

Valuation and Profitability Concerns Weighing on Sentiment

On the downside, certain financial metrics raise caution. The company’s operating profit to interest coverage ratio stands at a relatively low 5.90 times, which may signal tighter margins for servicing interest expenses. The debt-equity ratio, at 0.34 times, is the highest among its peers, indicating a comparatively higher reliance on debt financing. Additionally, the debtors turnover ratio is at a low 8.29 times, suggesting slower collection efficiency that could impact cash flows.

Fortis Healthcare’s return on capital employed (ROCE) is 11.9%, and it carries an enterprise value to capital employed multiple of 5.2, pointing to an expensive valuation relative to its earnings capacity. Although the stock trades at a discount compared to its peers’ historical averages, the price-earnings-to-growth (PEG) ratio of 2.2 indicates that the current price may already factor in substantial growth expectations. This elevated valuation could be contributing to the recent profit-taking and selling pressure.

Conclusion: Balancing Growth Potential with Near-Term Risks

In summary, Fortis Healthcare Ltd’s recent share price decline on 16-Mar reflects a combination of technical weakness, reduced investor participation, and valuation concerns despite the company’s strong growth fundamentals and solid institutional backing. While the stock has delivered exceptional returns over the medium to long term, near-term challenges such as elevated leverage ratios, slower debtor turnover, and an expensive valuation multiple have weighed on sentiment. Investors should carefully weigh these factors alongside the company’s robust operating profit growth and debt servicing ability when considering their positions in Fortis Healthcare.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →